Elevated expression of the leukemia-associated antigen SSX2IP predicts survival in acute myeloid leukemia patients who lack detectable cytogenetic rearrangements.

2.50
Hdl Handle:
http://hdl.handle.net/10547/224555
Title:
Elevated expression of the leukemia-associated antigen SSX2IP predicts survival in acute myeloid leukemia patients who lack detectable cytogenetic rearrangements.
Authors:
Guinn, Barbara-Ann; Greiner, Jochen; Schmitt, Michael; Mills, Ken I.
Citation:
Elevated expression of the leukemia-associated antigen SSX2IP predicts survival in acute myeloid leukemia patients who lack detectable cytogenetic rearrangements. 2009, 113 (5):1203-4 Blood
Publisher:
HighWire Press
Journal:
Blood
Issue Date:
29-Jan-2009
URI:
http://hdl.handle.net/10547/224555
DOI:
10.1182/blood-2008-09-178848
PubMed ID:
19179477
Additional Links:
http://bloodjournal.hematologylibrary.org/content/113/5/1203.long
Type:
Article
Language:
en
ISSN:
1528-0020
Sponsors:
Leukaemia and Lymphoma Research
Appears in Collections:
Biomedicine and Nutrition Research Group

Full metadata record

DC FieldValue Language
dc.contributor.authorGuinn, Barbara-Annen_GB
dc.contributor.authorGreiner, Jochenen_GB
dc.contributor.authorSchmitt, Michaelen_GB
dc.contributor.authorMills, Ken I.en_GB
dc.date.accessioned2012-05-18T10:41:42Z-
dc.date.available2012-05-18T10:41:42Z-
dc.date.issued2009-01-29-
dc.identifier.citationElevated expression of the leukemia-associated antigen SSX2IP predicts survival in acute myeloid leukemia patients who lack detectable cytogenetic rearrangements. 2009, 113 (5):1203-4 Blooden_GB
dc.identifier.issn1528-0020-
dc.identifier.pmid19179477-
dc.identifier.doi10.1182/blood-2008-09-178848-
dc.identifier.urihttp://hdl.handle.net/10547/224555-
dc.description.sponsorshipLeukaemia and Lymphoma Researchen_GB
dc.language.isoenen
dc.publisherHighWire Pressen_GB
dc.relation.urlhttp://bloodjournal.hematologylibrary.org/content/113/5/1203.longen_GB
dc.rightsArchived with thanks to Blooden_GB
dc.subjectSSX2IPen_GB
dc.subjectacute myeloid leukaemiaen_GB
dc.subjectsurvivalen_GB
dc.subjecttumour antigen expressionen_GB
dc.subject.meshAnimals-
dc.subject.meshAntigens, Neoplasm-
dc.subject.meshCOS Cells-
dc.subject.meshCercopithecus aethiops-
dc.subject.meshDisease-Free Survival-
dc.subject.meshEpitopes-
dc.subject.meshFemale-
dc.subject.meshGene Expression Regulation, Leukemic-
dc.subject.meshHL-60 Cells-
dc.subject.meshHumans-
dc.subject.meshImmunotherapy-
dc.subject.meshK562 Cells-
dc.subject.meshLeukemia, Myeloid, Acute-
dc.subject.meshMale-
dc.subject.meshPeptides-
dc.subject.meshPrognosis-
dc.subject.meshRNA, Neoplasm-
dc.subject.meshSurvival Rate-
dc.titleElevated expression of the leukemia-associated antigen SSX2IP predicts survival in acute myeloid leukemia patients who lack detectable cytogenetic rearrangements.en
dc.typeArticleen
dc.identifier.journalBlooden_GB

Related articles on PubMed

This item is licensed under a Creative Commons License
Creative Commons
All Items in UOBREP are protected by copyright, with all rights reserved, unless otherwise indicated.